Vnitr Lek 2018, 64(12):1148-1152
Bilirubin: from an unimportant waste product to important myocardial infarction predictor
- 1 Centrum experimentální medicíny IKEM, Praha
- 2 IV. interní klinika 1. LF UK a VFN v Praze
- 3 Ústav lékařské biochemie a laboratorní diagnostiky 1. LF UK a VFN v Praze
Bilirubin is the major catabolic product of heme degradation. It has long been regarded as an unimportant waste product. However, within the last twenty-five years, it has been demonstrated to play a very important role in maintaining the body's redox equilibrium. Disturbances of this equilibrium - increased oxidative stress - are currently considered one of the major risk factors for the development of non-communicable diseases. Although the exact mechanism is not known, a number of human studies have proved a reduced incidence of a number of (especially cardiovascular but also cancer) diseases in individuals with mildly elevated bilirubin concentrations.
Keywords: bilirubin; cardiovascular disease; morbidity; mortality
Received: October 22, 2018; Accepted: November 15, 2018; Published: December 1, 2018 Show citation
References
- Hunter DJ, Reddy KS. Noncommunicable diseases. N Engl J Med 2013; 369(14): 1336-1343. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMra1109345>.
Go to original source...
Go to PubMed...
- Wu LL. Review of risk factors for cardiovascular diseases. Ann Clin Lab Sci 1999; 29(2): 127-133.
- Hubacek JA, Stanek V, Gebauerova M et al. Traditional risk factors of acute coronary syndrome in four different male populations - total cholesterol value does not seem to be relevant risk factor. Physiol Res 2017; 66(Suppl 1): S121-S128.
Go to original source...
Go to PubMed...
- Tamosiunas A, Luksiene D, Baceviciene M et al. Health factors and risk of all-cause, cardiovascular, and coronary heart disease mortality: findings from the MONICA and HAPIEE studies in Lithuania. PLoS One 2014; 9(12): e114283. Dostupné z DOI: <http://dx.doi.org/10.1371/journal.pone.0114283>.
Go to original source...
Go to PubMed...
- Petursson H, Sigurdsson JA, Bengtsson C et al. Is the use of cholesterol in mortality risk algorithms in clinical guidelines valid? Ten years prospective data from the Norwegian HUNT 2 study. J Eval Clin Pract 2012; 18(1): 159-168. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1365-2753.2011.01767.x>.
Go to original source...
Go to PubMed...
- Hubáček J. Základy genetické determinace civilizačních onemocnění. Postgrad Med 2018; 20(Supl 1): 6-10.
- O'Donnell CJ, Nabel EG. Genomics of cardiovascular disease. N Engl J Med 2011; 365(22): 2098-2109. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMra1105239>.
Go to original source...
Go to PubMed...
- Ezzati M, Riboli E. Behavioral and dietary risk factors for noncommunicable diseases. N Engl J Med 2013; 369(10): 954-964. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMra1203528>.
Go to original source...
Go to PubMed...
- Koene RJ, Prizment AE, Blaes A et al. Shared risk factors in cardiovascular disease and cancer. Circulation 2016; 133(11): 1104-1114. Dostupné z DOI: <http://dx.doi.org/10.1161/CIRCULATIONAHA.115.020406>.
Go to original source...
Go to PubMed...
- Virchow R. Die Pathologischen Pigmente. In Virchow R, Reinhardt B (eds). Archiv für pathologische Anatomie und Physiologie und Klinische Medicin (Virchow's Archiv) 1847; 1:407. Dostupné z DOI: <http://doi.org/10.1007/BF02114470>.
- Vitek L, Ostrow JD. Bilirubin chemistry and metabolism; harmful and protective aspects. Curr Pharm Des 2009; 15(25): 2869-2883.
Go to original source...
Go to PubMed...
- Zucker SD, Horn PS, Sherman KE. Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer. Hepatology 2004; 40(4): 827-835. Dostupné z DOI: <http://dx.doi.org/10.1002/hep.20407>.
Go to original source...
Go to PubMed...
- Johnson AD, Kavousi M, Smith AV et al. Genome-wide association meta-analysis for total serum bilirubin levels. Hum Mol Genet 2009; 18(14): 2700-2710. Dostupné z DOI: <http://dx.doi.org/10.1093/hmg/ddp202>.
Go to original source...
Go to PubMed...
- Stocker R, Yamamoto Y, McDonagh AF et al. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235(4792): 1043-1046.
Go to original source...
Go to PubMed...
- Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 2006; 86(2): 583-650. Dostupné z DOI: <http://dx.doi.org/10.1152/physrev.00011.2005>.
Go to original source...
Go to PubMed...
- Vítek L. Úloha bilirubínu v prevenci kardiovaskulárních a nádorových onemocnění. Čas Lék Česk 2016; 155(2): 10-14.
Go to PubMed...
- Vítek L. Bilirubin and atherosclerotic diseases. Physiol Res 2017; 66(Suppl 1): S11-S20.
Go to original source...
Go to PubMed...
- Vítek L. Vztah bilirubinu k nemocem vyvolaným zvýšeným oxidačním stresem. Vnitř Lék 2013; 59(7): 618-621.
Go to PubMed...
- Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 1994; 40(1): 18-23.
Go to original source...
- Hopkins PN, Wu LL, Hunt SC et al. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol 1996; 16(2): 250-255.
Go to original source...
Go to PubMed...
- Kunutsor SK, Bakker SJ, Gansevoort RT et al. Circulating total bilirubin and risk of incident cardiovascular disease in the general population. Arterioscler Thromb Vasc Biol 2015; 35(3): 716-724. Dostupné z DOI: <http://dx.doi.org/10.1161/ATVBAHA.114.304929>.
Go to original source...
Go to PubMed...
- Kang SJ, Kim D, Park HE et al. Elevated serum bilirubin levels are inversely associated with coronary artery atherosclerosis. Atherosclerosis 2013; 230(2): 242-248. <http://dx.doi.org/10.1016/j.atherosclerosis.2013.06.021>.
Go to original source...
Go to PubMed...
- Horsfall LJ, Nazareth I, Petersen I. Cardiovascular events as a function of serum bilirubin levels in a large, statin-treated cohort. Circulation 2012; 126(22): 2556-2564. Dostupné z DOI: <http://dx.doi.org/10.1161/CIRCULATIONAHA.112.114066>.
Go to original source...
Go to PubMed...
- Marconi VC, Duncan MS, So-Armah K et al. Bilirubin is inversely associated with cardiovascular disease among HIV-positive and HIV-negative individuals in VACS (Veterans Aging Cohort Study). J Am Heart Assoc 2018; 7(10): pii: e007792. Dostupné z DOI: <http://dx.doi.org/10.1161/JAHA.117.007792>.
Go to original source...
Go to PubMed...
- Suh S, Cho YR, Park MK et al. Relationship between serum bilirubin levels and cardiovascular disease. PLoS One 2018; 13(2): e0193041. Dostupné z DOI: <http://dx.doi.org/10.1371/journal.pone.0193041>.
Go to original source...
Go to PubMed...
- Lingenhel A, Kollerits B, Schwaiger JP et al. Serum bilirubin levels, UGT1A1 polymorphisms and risk for coronary artery disease. Exp Gerontol 2008; 43(12): 1102-1107. Dostupné z DOI: <http://dx.doi.org/10.1016/j.exger.2008.08.047>.
Go to original source...
Go to PubMed...
- Breimer LH, Mikhailidis DP. Is bilirubin a marker of vascular disease and/or cancer and is it a potential therapeutic target? Curr Pharm Des 2011; 17(33): 3644-3655.
Go to original source...
Go to PubMed...
- Wagner KH, Wallner M, Mölzer C et al. Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases. Clin Sci (Lond) 2015; 129(1): 1-25. <http://dx.doi.org/10.1042/CS20140566>.
Go to original source...
Go to PubMed...
- Gazzin S, Vitek L, Watchko J et al. A novel perspective on the biology of bilirubin in health and disease. Trends Mol Med 2016; 22: 758-768.
Go to original source...
Go to PubMed...
- Oda E. Does serum builirubin prevent cardiovascular disease? J Xiangya Med 2017; 2: 58. Dostupné z DOI: <http://dx.doi.org/10.21037/jxym.2017.07.05>.
Go to original source...
- Ong KL, Allison MA, Cheung BM et al. The relationship between total bilirubin levels and total mortality in older adults: the United States National Health and Nutrition Examination Survey (NHANES) 1999-2004. PLoS One 2014; 9(4): e94479. Dostupné z DOI: <http://dx.doi.org/10.1371/journal.pone.0094479>.
Go to original source...
Go to PubMed...
- Mahabadi AA, Lehmann N, Möhlenkamp S et al. Association of bilirubin with coronary artery calcification and cardiovascular events in the general population without known liver disease: the Heinz Nixdorf Recall study. Clin Res Cardiol 2014; 103(8): 647-653. Dostupné z DOI: <http://dx.doi.org/10.1007/s00392-014-0697-z>.
Go to original source...
Go to PubMed...
- Kimm H, Yun JE, Jo J et al. Low serum bilirubin level as an independent predictor of stroke incidence: a prospective study in Korean men and women. Stroke 2009; 40(11): 3422-3427. Dostupné z DOI: <http://dx.doi.org/10.1161/STROKEAHA.109.560649>.
Go to original source...
Go to PubMed...
- Gul M, Kalkan AK, Uyarel H. Serum bilirubin: a friendly or an enemy against cardiovascular diseases? J Crit Care 2014; 29(2): 305-306. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jcrc.2013.11.019>.
Go to original source...
Go to PubMed...
- Stender S, Frikke-Schmidt R, Nordestgaard BG et al. Genetically elevated bilirubin and risk of ischaemic heart disease: three Mendelian randomization studies and a meta-analysis. J Intern Med 2013; 273(1): 59-68. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1365-2796.2012.02576.x>.
Go to original source...
Go to PubMed...
- Bian LQ, Li RZ, Zhang ZY et al. Effects of total bilirubin on the prevalence of osteoporosis in postmenopausal women without potential liver disease. J Bone Miner Metab 2013; 31(6): 637-643. Dostupné z DOI: <http://dx.doi.org/10.1007/s00774-013-0452-y>.
Go to original source...
Go to PubMed...
- Apperley S, Park HY, Holmes DT et al. Serum bilirubin and disease progression in mild COPD. Chest 2015; 148(1): 169-175. Dostupné z DOI: <http://dx.doi.org/10.1378/chest.14-2150>.
Go to original source...
Go to PubMed...
- Peng F, Deng X, Yu Y et al. Serum bilirubin concentrations and multiple sclerosis. J Clin Neurosci 2011; 18(10): 1355-1359. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jocn.2011.02.023>.
Go to original source...
Go to PubMed...
- Balta S, Balta I, Mikhailidis DP et al. Bilirubin levels and their association with carotid intima media thickness and high-sensitivity C-reactive protein in patients with psoriasis vulgaris. Am J Clin Dermatol 2014; 15(2): 137-142. Dostupné z DOI: <http://dx.doi.org/10.1007/s40257-014-0069-5>.
Go to original source...
Go to PubMed...
- Zhao J, Tan S, Liu F et al. Heme oxygenase and ocular disease: a review of the literature. Curr Eye Res 2012; 37(11): 955-960. Dostupné z DOI: <http://dx.doi.org/10.3109/02713683.2012.700753>.
Go to original source...
Go to PubMed...
- Vitek L, Novotná M, Lenícek M et al. Serum bilirubin levels and UGT1A1 promoter variants in patients with schizophrenia. Psychiatry Res 2010; 178(2): 449-450. Dostupné z DOI: <http://dx.doi.org/10.1016/j.psychres.2009.12.008>.
Go to original source...
Go to PubMed...
- Gama-Marques J, Tinoco I, Pedro I et al. Unconjugated bilirubin and acute schizophrenia: a probable correlation? Actas Esp Psiquiatr 2017; 45(2): 79-88.
- Cao L, Xue L, Luo DM. Lower serum bilirubin concentration in patients with migraine. Int J Clin Exp Med 2015; 8(8): 13398-13402.
- Kim TS, Pae CU, Yoon SJ et al. Decreased plasma antioxidants in patients with Alzheimer's disease. Int J Geriatr Psychiatry 2006; 21(4): 344-348. Dostupné z DOI: <http://dx.doi.org/10.1002/gps.1469>.
Go to original source...
Go to PubMed...